The goal of the American Diabetes Association’s Pathway to Stop Diabetes program is simple, yet revolutionary: find a new generation of scientists at the peak of their creativity, and provide them with the freedom, autonomy, and resources to set them on the road to breakthrough discoveries in translational science that lead to breakthroughs in diabetes science.
The Pathway to Stop Diabetes program is designed to transform diabetes research (link is external)by attracting innovative scientists, physicians, and researchers through financial support and professional mentorship.
Since the program’s inception in 2014, 36 scientists have been selected and 100 percent have secured their first independent faculty positions, 46 invention disclosures and patent applications have been filed, 16 start-ups have been launched, and over 233 manuscripts have been published in peer-reviewed journals by Pathway awardees. After a pause in the program due to the COVID-19 pandemic, the ADA is proud to renew the program and continue fostering new leadership and medical breakthroughs for diabetes research.
ADA's Pathway to Stop Diabetes initiative is transforming diabetes research and improving the lives of people living with diabetes or its burdens.
Each institution is allowed a maximum of one nomination in one of the two available Pathway award types.
Deadlines:
- Duke Internal: June 15, 2023
- Sponsor Deadline: Aug. 1, 2023